CS logo
small CS logo
Mt. Sinai Medical Center Division of Hematology/Oncology

New York, New York, United States

About Mt. Sinai Medical Center Division of Hematology/Oncology


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Mt. Sinai Medical Center Division of Hematology/Oncology


During the past decade, Mt. Sinai Medical Center Division of Hematology/Oncology conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Mt. Sinai Medical Center Division of Hematology/Oncology" #1 collaborator was "bluebird bio" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

Clinical Trials Conditions at Mt. Sinai Medical Center Division of Hematology/Oncology


According to Clinical.Site data, the most researched conditions in "Mt. Sinai Medical Center Division of Hematology/Oncology" are "Multiple Myeloma" (3 trials) and "Leukemia, Myeloid" (1 trials). Many other conditions were trialed in "Mt. Sinai Medical Center Division of Hematology/Oncology" in a lesser frequency.

Clinical Trials Intervention Types at Mt. Sinai Medical Center Division of Hematology/Oncology


Most popular intervention types in "Mt. Sinai Medical Center Division of Hematology/Oncology" are "Drug" (3 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "ACY-1215 (Ricolinostat) in combination with pomalidomide and dexamethasone" (1 trials), "CC-92328" (1 trials), "CC-96191" (1 trials) and "bb2121" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Mt. Sinai Medical Center Division of Hematology/Oncology


The vast majority of trials in "Mt. Sinai Medical Center Division of Hematology/Oncology" are 4 trials for "All" genders.

Clinical Trials Status at Mt. Sinai Medical Center Division of Hematology/Oncology


Currently, there are NaN active trials in "Mt. Sinai Medical Center Division of Hematology/Oncology". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Mt. Sinai Medical Center Division of Hematology/Oncology, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Mt. Sinai Medical Center Division of Hematology/Oncology, 4 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".